Tissue Engineering and Regeneration: Technologies and Global Markets
LONDON, Nov. 25, 2014 /PRNewswire/ -- This BCC Research report presents an in-depth analysis of the global tissue engineering and regeneration market by technologies, materials, applications segments and regional markets. It includes comprehensive patent analysis that focuses on providing extensive technological trends across years and regions, including the U.S., Europe and Japan.
Use this report to:
- Receive an in-depth analysis of the global tissue engineering and regeneration market by technologies, materials, applications segments and regional markets.
- Receive an in-depth analysis of key companies operating in the global tissue engineering and regeneration market.
- Know the government regulations and legislations for tissue engineering and regenerative medicines.
- Identify major stakeholders, product portfolios and recent developments, and draw a competitive landscape for the market leaders.
Highlights
- The global tissue engineering and regeneration market reached $17 billion in 2013. This market is expected to grow to nearly $20.8 billion in 2014 and $56.9 billion in 2019, a
compound annual growth rate(CAGR) of 22.3%.
- The North American market reached $7.3 billion in 2013. This market is expected to grow to nearly $9 billion in 2014 and $22.8 billion in 2019, a CAGR of 20.5%.
- The Eupropean market reached nearly $6.9 billion in 2013. This market is expected to grow to nearly $8.3 billion in 2014 and $22.3 billion in 2019, a CAGR of 21.9%.
Introduction & Scope
INTRODUCTION
STUDY AND OBJECTIVE
- Define and identify key market segments and market structure in the tissue engineering and regeneration market.
- Measure and estimate the global tissue engineering and regeneration market and its market segments, including technologies, materials, applications and geographic
regions.
- Identify key market dynamics and the factors impacting the global tissue engineering and regeneration market and its sub-segments.
- Identify the trends, gaps and opportunities in each of the micromarkets.
- Focus exclusively on geographic segmentation. Analyze trends and opportunities in the major regions: North America, Europe, Asia-Pacific and the Rest of the World
(ROW).
- Identify major stakeholders, product portfolios and recent developments, and draw a competitive landscape for the market leaders.
SCOPE OF THE REPORT
This research report presents an in-depth analysis of the global tissue engineering and regeneration market by technologies, materials, applications segments and regional
markets. It includes key technologies involved in stem cell therapies and cell therapies. It analyzes the clinical trials and patents conducted in respective geographies. The
report is an in-depth analysis of key companies operating in the global tissue engineering and regeneration market. It includes in-depth patent analysis that focuses
on providing extensive technological trends across years and across regions, including the U.S., Europe and Japan.
The tissue engineering and regeneration market is mainly segmented into three classes: synthetic, genetically modified and biological materials. Synthetic materials
are further categorized into biodegradable synthetic polymers, scaffold (medical poly lactic acid), artificial vascular graft materials and hydrogeltechnology. The biologically
derived materials are segmented into, xenogenic tissue and collagen. The ablation device application market is further segmented on the basis of various applications for
in-depth analysis of technology markets. The market study is detailed for application based on procedures, as well as its further implication on the therapeutic area. These
two segments are also discussed in detailed for the forecast period. The market is segmented by region into the Americas, Europe, Asia-Pacific and ROW. Companies
profiled in this report include Advanced Cell Technology, Arteriocyte, Athersys, Bioheart, BioMimetic Therapeutics, BioTissue Technologies, CeraPedics, Cook Biotech,
CryoLife, Cytograft Tissue Engineering, Cytomedix, Cytori Therapeutics, Genzyme/Sanofi, Integra LifeSciences, International Stem Cell, LifeCell/Kinetic Concepts and Mesoblast.
INTENDED AUDIENCE
This report's intended audience includes:
- Tissue engineering equipment and device manufacturers and potential entrants.
- Tissue engineering and regeneration device dealers, distributors and service providers.
- Healthcare service providers and private research institutes.
- Government authorities and public service boards.
- Research institutes, associations and academics.
INFORMATION AND METHODOLOGY SOURCES
- The global tissue engineering and regeneration market was assessed and calculated via a bottom-up approach that involved identifying the market revenues of the
micromarkets that make up the macromarkets. This process was designed to ensure quality and consistency of estimates.
- In-depth primary and secondary research was conducted.
- Primary research entailed gathering intelligence from key market players. The interview participants included CEOs, key opinion leaders, product heads and
directors.
- Secondary research included the collation of data from freely available sources, as well as from paid subscriptions to specialized industry magazines and websites.
- The derived values were validated through primary research to best assure the triangulation of market estimates.
- Key factors considered during market estimations were price, volumes, incidence and prevalence rates, and the number of procedures.
- Regional segmentation was assessed through various parameters, including the number of players in a particular region, incidence and prevalence rates, the extent
of research activity occurring in that geography and future potential.
Download the full report: https://www.reportbuyer.com/product/2313354/
About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers
http://www.reportbuyer.com
For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: [email protected]
Tel: +44 208 816 85 48
Website: www.reportbuyer.com
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/tissue-engineering-and-regeneration-technologies-and-global-markets-300001191.html
SOURCE ReportBuyer
Share this article